These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19943340)

  • 21. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
    Blasko I; Stampfer-Kountchev M; Robatscher P; Veerhuis R; Eikelenboom P; Grubeck-Loebenstein B
    Aging Cell; 2004 Aug; 3(4):169-76. PubMed ID: 15268750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
    Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
    Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes].
    Fukatsu R; Tsuzuki K; Hayashi Y; Takamaru Y; Sasaki N; Yoshida T; Hatakeyama Y; Fuji N; Takahata N
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):3-11. PubMed ID: 9086357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postischemic dementia with Alzheimer phenotype: selectively vulnerable versus resistant areas of the brain and neurodegeneration versus β-amyloid peptide.
    Pluta R; Jabłoński M; Czuczwar SJ
    Folia Neuropathol; 2012; 50(2):101-9. PubMed ID: 22773455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells.
    Kazmierczak A; Strosznajder JB; Adamczyk A
    Neurochem Int; 2008 Dec; 53(6-8):263-9. PubMed ID: 18804502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta-Secretase, APP and Abeta in Alzheimer's disease.
    Vassar R
    Subcell Biochem; 2005; 38():79-103. PubMed ID: 15709474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advances in molecular pathology of Alzheimer's disease].
    Coria-Balanzat F
    Rev Neurol; 2006 Mar 1-15; 42(5):306-9. PubMed ID: 16538595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of Alzheimer's disease and dementia.
    Bugiani O
    Rev Neurol (Paris); 1999; 155 Suppl 4():S28-32. PubMed ID: 10637935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
    Wyss-Coray T
    J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease. A new take on tau.
    Marx J
    Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
    [No Abstract]   [Full Text] [Related]  

  • 34. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
    Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S
    Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis of Alzheimer's disease].
    Alegre M; Noé E; Luquin MR
    Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The amyloid peptide and its precursor in Alzheimer's disease.
    Octave JN
    Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis.
    Marcello E; Epis R; Di Luca M
    Eur J Pharmacol; 2008 May; 585(1):109-18. PubMed ID: 18377893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimmunomodulation in the pathogenesis of Alzheimer's disease.
    Morales I; Farías G; Maccioni RB
    Neuroimmunomodulation; 2010; 17(3):202-4. PubMed ID: 20134203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.